Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07144761 · ClinicalTrials.gov registry record · NA
Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™
A NA study of Blepharoplasty, sponsored by Osheru.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 5
- Study locations
NCT07144761: Recruiting NA study of Blepharoplasty, sponsored by Osheru.
NCT07144761 is a NA study of Blepharoplasty that is actively recruiting participants, run by Osheru. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07144761, a NA study of Blepharoplasty, is actively recruiting participants, sponsored by Osheru.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective of this study is to evaluate patient-reported outcomes, surgeon reported outcomes, bruising, symmetry, the success of tissue adhesive for wound closure, and case time.
Primary Outcome
Demonstrate an improvement in overall patient satisfaction by comparing pre-operative and post-operative patient reported outcome scores. FACE-Q - Aesthetics - Appearance - Satisfaction with facial appearance FACE-Q - Aesthetics - Appearance - Satisfaction with Eyes On a scale of 1-4 Very Dissatisfied being 1 and Very Satisfied being 4
Conditions Studied
Interventions
- DEVICE Ziplyft
Study Locations (5)
Florida
- Center for Excellence in Eye Care - Miami
Minnesota
- Vance Thompson Vision - Alexandria
Pennsylvania
- Eye Care Specialists - Kingston
South Dakota
- Vance Thompson Vision - Sioux Falls
Wisconsin
- The Eye Centers of Racine and Kenosha, LTD - Kenosha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-08 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT07144761 shows while recruiting
NCT07144761 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Blepharoplasty appearing as the primary indexed condition, and to 1 intervention - of which Ziplyft is the first listed.
NCT07144761 lists 5 locations in 5 states (Florida, Minnesota, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT07144761 about?
NCT07144761 is a clinical study titled "Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™". The objective of this study is to evaluate patient-reported outcomes, surgeon reported outcomes, bruising, symmetry, the success of tissue adhesive for wound closure, and case time.
What is the current status of trial NCT07144761?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-08. Estimated completion is 2025-12.
What conditions does trial NCT07144761 study?
This clinical trial studies the following conditions: Blepharoplasty.
What interventions are being tested in trial NCT07144761?
The interventions under investigation include: Ziplyft (DEVICE).
Who is sponsoring clinical trial NCT07144761?
This trial is sponsored by Osheru, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07144761 being conducted?
This trial has 5 study locations across Florida, Minnesota, Pennsylvania, South Dakota, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blepharoplasty
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07144761's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia